fully implemented in the ir respective clinical settings. Furthermore, clini cal personnel identified lack of knowledge and or ganizational factors-such as communication difficulties across teams, shifts, and hospital departments-as th e biggest barriers to implementing CPGs [5] . The effective selection and implementation of evidence-based guidelines for PU are critically important to improving rehabilitative and lifetime outcomes for people at risk for PU development. Education in the us e and implementation of CPGs is an ongoing need. Additionally, a critical need exists to ide ntify the remaining r esearch gaps and pathways to ef fective implementation o f research efforts in clinical practice.
An invited expert panel met in Cleveland, Ohio, on June 4, 2009 , in conjun ction with the 2nd International Conference on Evidence Based Practice in Wound Care, to develop a research agenda based on critical knowledge gaps regarding PUs in individuals with S CI and on i mplementation of adva nced clinical practice. We report a literature-based discussion of the consensus pa nel conclusions. The meeting was sponsored by the De partment of Veterans Affairs (VA) SCI Quality Enhancement Research Initiative (SCI QUERI).
The SCI QUERI works closely with the V A's SCI/D Strategic Health Group to identify the critical, time-sensitive issues important for V eterans Health Administration operations as part of the SCI QUERI mission: promotion of patient health, functioning, and quality of life through the implementation of evidence-based methods for enhancing patient self-management and disease p revention in the context of multidisciplinary care. PUs are a significant clinical problem in the SCI population and are a primary area of research focus.
PANEL FORMAT
The multidisciplinary expert panel consisted of a balanced mix of clinicians and researchers, integrating physicians, nurses, engineers, and physical therapists with both health se rvices and rehabilitation researchers. VA research leaders attended, and the VA Rehabilitation and Res earch Service and the VA Office of Nursing Service were also involved since a critical need re mains for preclinical and clinic al pilot-phase research in PU management (see Appendix for panel membership, available online only).
The panel's mission was to develop consensus on a focused research agenda to address the critical gaps extant in eviden ce-based knowledge of PU care and to f acilitate large-scale implementation of advanced clinical practice.
Panel discussions were divided into three sessions: (1) primary prevention-reducing the incidence of PUs, identifying high-risk patients, and developing models of rehabilitation a nd education; (2) secondary prevention-performing early/routine assessments and reducing recurrence of PU; and (3) te rtiary prevention-treating and reducing disease-related complications [6] . Panel discus sions used the SCICPG as an underlying guide.
While panel discussions were segregated by prevention level, several topics are clearly relevant to more than one aspect of PU prevention and/or management. For example, hete rotopic ossification (HO) is potentially important in both primary and secondary prevention. Therefore, our di scussion in this ar ticle is organized by the overarching categories of risk factors (ranging from the cellular level to the patient and environment), clinical management (at the patient, clinical microsystem, and clinical macrosystem level), education (of patient, caregivers, clinicians, and administrators), and environment of care (macrosystem).
The expert panel conducted a follow-up survey to prioritize the research gaps identified during panel discussions. Panel participants were asked to prioritize research topics, from the perspective of their individual expertise, in the four domains discussed. Panelists ranked what they cons idered the most ur gent research areas using a mu ltiple selection format. Selections were limited to the top three research themes in the domains of risk factors and clinical management and the top two re search themes in the domains of education and environment of care. Validation measures were employed to ensure survey integrity. The survey was hosted on the online survey provider Question Pro (http://www.questionpro.com/). High-priority research top ics were designated based on percentage of panel responses.
Population Risk Disparities
Several disparities in PU risk based on population warrant further research. While risk factors are widely agreed upon, the relative weight of these factors and their importance w ith respect to recurrence have not been established and probably vary across patient groups [8] . The panel considered that further research is needed to establish whether factors that predict PU recur rence in the SCI/D population are similar to those in other high-risk populat ions, such as the older population and individuals with multiple sclerosis. Even wit hin the SCI/D population there are differences between veterans and other SCI/D groups [9] . Much of the published research on risk factors for PUs focuse s on either nursi ng home residents or on the populati on with acute SCI/D; the degree to which these risk factors apply to other populations has not been established. VA hospitals have a high proportion of individuals with long-term, chronic SCI (time since injury approximately 20 years) [10] [11] who receive life-long care in both urban and rural areas, whereas M odel SCI Systems Centers focus primarily on acute traumatic SCI in the urban areas. PU risk factors may possibly differ between these populations. Recurrence rates are known to be significant, ranging from 31 to 79 percent [12] [13] [14] [15] [16] . Data exist on possible risk fa ctors for re current PUs; however, there is little information on characteristics of recurrence [17] .
Mechanical Risk
The etiology and biomech anics of PU development remain topics for fu rther investigation. Clinically, it is known that tissue breakdown can originate both at the skin surface and in deep tissues [18] [19] . Histological studies have shown that deep tissue often shows significa nt damage before any superficial damage is visible [20] . Recent preclinical studies indicate that deep-tissue loads, in particular internal strains, may be important factors [21] [22] . Further preclinical studies are in progress to fully characterize these models. Research is also needed to establish the pa thway for translation and clinical practice implemen tation of biomechanical interventions to prevent skin breakdown.
Cellular-Level Risk
Biomolecular aspects of PU development are incompletely characterized and need further research. The effects of mechanical loading on cytokine release from the skin surface have been investigated in an in vitro model [23] [24] . A pi lot study by Sari et al.
evaluated creatine phosphoki nase levels in wound exudate as a potential indicator of DTI in an animal model [25] . In the field of diabetic ulcer management, nitric oxide levels in w ound fluid have recently been proposed as indicators of wound healing [26] . While using wound exudate as the source for biomarkers [27] could increase know ledge of the processes involved in tissue breakdow n and/or healing, implicitly this approach could not facilitate primary or secondary prevention. The pa nel considered that centralized banking of wound tissues could provide a resource to advance the basic research still required to understand the biochemical pr ecursors to PU development. Several commercial tissue banks exist that can provide a variety of tissues. The National Disease Research Interchange (NDRI) is a not-for -profit corporation, supported by the National Institutes of Health, that provides huma n cells and tissues for research. Currently th ese tissue books tend to focus on specific disease etiologies, such as cancer, arthritis, and heart disease; however, NDRI could act as a broker to obtain wound tissues [28] . In addition, tissue from PU sur geries could be a valuable resource for tissue banking.
Risk Assessment
The panel recognized a continuing need for standardized assessment tools that would enable practit ioners to identify PUs befo re tissue damage becomes clinically noticeable. Such tools are needed for all patient groups. The challenge of detecting early skin damage, i.e., stage I PUs, in individuals with darker skin is even greater than in the overall at-risk population. Advanced imaging techniques are being investigated that have the poten tial to improve primary prevention for these individuals [29] [30] . Measurement of subepidermal moisture has been reported as a potential technique for de tecting early PUs in ind ividuals with dark skin [ 31] , thus improving care for this patient population. Multispectral imaging has been reported as a potenti al method for detecting erythema in individuals with dark skin pigment [32] . Initial e valuations have been performed of diagnostic ultrasound [33] [34] [35] [36] , three-dimensional elastography [37] [38] , and me thods to assess tissue viscoelasticity [39] for identifying and predicting progression of DTI to fulm inant PUs and assessing deep tissue strains in indi viduals with SCI. Further research is needed to establish reliability and ef ficacy in order to provide a sound basis for clinical implementation of interventions utilizing newer technologies for all individuals at risk for PU development.
Physiological Risk
The panel considered spec ific clinical facto rs within the SCI/D population that significantly affect PU risk status. For example, individuals with tetraplegia frequently have uncompensated hypotension combined with poor or absent venous return. These population-specific cardiovascular changes may be significant risk factors in PU development [40] .
HO is also a well-know n complication of SCI and has been linked to PU incidence [41] [42] [43] , but the mechanism driving unc ontrolled promotion of osteogenesis following SC I has not been investigated. A recent study in pa tients with traumatic brain injury (TBI) indica ted that both osteoblast proliferation and differentiation are increased acutely following TBI [44] . Increa sed osteoblast activity is an indicator of HO, suggesting that further research in the SCI population may be warranted. The precise relationship betwee n HO and PU formation remains to be determined.
Although specific patie nt groups have been defined as being at high risk of PU development, the effect of comorbidities has not been investigated in the population with SCI. For example, chronic obstructive pulmonary disease (COPD) was found to be associated with PUs in an outpatient geriatric population [45] . This area of re search may benefit from preclinical modeling using the large databases available to VA researchers through the V A Information Resource Center [46] or the National Surgery Quality Improvement Program [47] . Additionally, the panel considered that clin ical studies are needed regarding the effect of factors such as diabetes and obesity on PU development and/or recurrence.
Aging-Related Risk
The risk of PU development and/or recurrence may also be af fected by comorbidities that develop over time. Extensive longitudinal cohort studies have shown that aging with an SCI accelerates degenerative changes in health st atus [48] [49] . Reports of the relationship between PU a nd time since injury are less consistent [8, [50] [51] . The panel co nsidered that research in the SCI vete ran population would be valuable in addressing these questions.
Environmental Risk
Knowledge of how extrin sic environmental factors contribute to forma tion and recurrence of PUs remains incomplete. Environmental risk factors include the local skin envi ronment (e.g., moisture level secondary to sweatin g and bowel or bladder incontinence), interface press ure and sh ear force between the skin and the support surface, friction [52] , residential situation, and ps ychosocial support. These factors may interact with intrinsic physical/medical risk factors to increase PU risk. Certain environments are known to be associated with hi gher incidence of PUs, e.g., inte nsive care units (ICUs) and surgery. Recent VA quality improve ment data from t he VA Nursing Outcome database * (second quarter o f fiscal year 2008-final quarter of fiscal year 2010) indicate that the average rate of hospital-acquired ulcers is low (2.2%) in VA SCI Centers. Further research into high-risk settings for PU development, especially for community-dwelling individuals with SCI/D, is warranted.
Nutritional Risk
The SCICPG suggest th at general nutritional status is important in PU development and healing. In addition, the NPUAP Whit e Paper on the role of nutrition in preventing and treating PUs advises that early nutrition screeni ng provides a window for identification of PU risk. However , although the NPUAP provides guidelines for nutritional assessment and management of individuals with preexisting PUs [53] , there is little evidence supporting use of specific nutritiona l therapies for preventing and treating PU. Our panel deemed that further research is needed into the ef fects of sp ecific dietary elements in individuals with SCI/D, e.g., the potential role of proinf lammatory diets in both acute and chronic SCI/D.
Pressure Ulcer Risk Assessment
As noted previously, it is well recognized that prevention of PUs involves many factors. The correction of all risk factors for an individual with SCI/D can be both overwhelming and imprac tical to implement in clinical practice. The relative importance of both independent and dependent risk factors for PU prevention has not been investigated. A pilot study to differentiate degrees of risk in criti cally ill people was reported over 15 years ago [54] but ha s not been further developed. The Salzberg risk assessment scale, developed for SCI, focused on 15 risk factors, including urinary incontinence, autonomic dysreflexia, card iac/pulmonary/renal/diabetic comorbidities, impaired cognitive function, cigarette smoking, residence in a nursing home or hospital, hypoalbuminemia, and anemia [55] [56] but has not been further evaluated for validity and reliability [3] . The panel suggested that research is needed to develop weighted models of risk factors to enable ef ficient direction of clinical resources for effective primary PU pr evention in the population with SCI/D. The panel concluded that standardized and comprehensive documentation of PU risk factors and treatments could potentially help reduce both PU development and recurrence rates. Clinical and health services research is needed to d evelop and implement appropriate and effective documentation.
Education
Education and awareness are critically important to prevent PUs. Educational programs may be directed to healthcare prof essionals, i.e., physicians, nurses, and nursing assistants, as well as to individuals with SCI, their fa milies, and caregivers. The SCICPG recommend providing these individuals with information on ef fective strategies to prevent and treat PUs [4] . The panel discussed the continuing need for research regarding the most ef fective ways to educate all groups involved in PU prevention. Knowledge of how best to educate patients and providers is necessary for the development of comprehensive and ef fective tools tailored to the individual's learning style. T o be effective, education must motivate the at-risk individual and his/her provider to both learn and act on the information.
Effective primary prevention requires accurately identifying at-risk individuals, implementing appropriate preventative measures, and identifying early-stage tissue damage. Continuing education and collaboration is required to mainta in the knowledge needed to perform these tasks. In the acute setting, education of clinical staff is important to improve PU awareness and to promote primary prev ention strategies. Studies have shown that there is wide variation in nursing knowledge and implementati on of PU preventive measures [57] . A significa nt drop in PU knowledge retained by critical-care a nd medical-surgical nurses was found 3 months after part icipation in a tar geted learning activity [58] . Quar terly continuing education on PU prevention for all clin ical staff involved with care of persons with SCI ma y be beneficial. Further research is needed to el ucidate best practice for continuing education regardi ng primary prevention of PUs in the acute period post-SCI.
Nosocomial development of primary and recurrent PUs also varies in dif ferent healthcare settings and/or populations. In part icular, serious illness requiring ICU admission and prolonged sur gical procedures will both affect overall risk status. However, the primary risk fact ors involved will vary by patient and by setting. The panel considered that specific guidelines are needed for healthcare professionals working in thes e settings. Research is needed both to develop appropriate guidelines and to increase awareness amongst acute-care providers who traditionally may not regard PU prevention in populations with SCI/D as a priority.
Many clinical programs have recognized the need for early and comprehensive patient education during SCI rehabilitation. Sheppard et al. found that patients who had developed skin breakdown had poor knowledge about skin care [59] . This suggests that reinforcement of p atient education at every practical opportunity woul d be highly beneficial. The panel considered that it was also important for nonprofessional caregivers, such as family members, to be included in the educational process.
The SCICPG suggest th at appropriate educational programs, which empower patients to take responsibility for skin care, are valuable for decreasing recurrence. However, research is needed to determine which approaches work best for different populations of individuals with SCI. Some research suggests that incentives can improve patient and provider participation in skin protective behaviors [60] [61] . Determ ining of which incentives are ef fective, sustainable, and reproducible remains an area for future research.
Tertiary prevention of PUs is focused on minimizing the incidence of further related complications. The VA "Hub-and-Spoke" sy stem was desi gned to ensure that all veterans with SCI have access to relevant clinical expertise. Within the veterans healthcare system, the SCI Ce nter is the hub, with some less specialized PU care provid ed at the spoke facilities within the hub' s associated SCI ser vice areas. The educational goals for clinical teams at V A spoke facilities include knowledge of PU risk factors and potential complications. The pa nel considered that further research is needed to evaluate how to ef fectively disseminate information on best practices to spoke site community providers.
Clinical Management
Clinical management of PU prevention and treatment is complex because of the many risk factors and environmental contributions to their formation. The SCICPG includes 32 separa te recommendations. It would be very challenging and unrea listic to expect all recommendations be implemented concurrently. Providers and patients ma y feel overwhelmed by the numerous instructions for managing PUs. Moreover, few of these recommendations are evidence-based.
The clinical decisionmaking process is further complicated by the fact that the SCICPG weight all recommendations equally, which does not aid clinicians during a clinical decisionmaking process that is characterized by multiple competing priorities. The panel recommended further evaluation of the ef fect of adhering to all CPG-recommended behaviors. The effect can be studied from several angles, including clinical outcomes such as decreased incidence and reduced recurrence rates.
Planning for Prevention
The SCICPG support tailo ring PU prevention programs to specific patient populations. Key differences exist between the popul ation of persons with SCI/D and other at-risk groups (such as elderly nursing home residents) in mu scle remodeling and atrophy [62] [63] [64] . For example, the primary diagnosis of SCI/D is a much more st able condition than the degenerative aging process, and loss of appetite is more frequent in the olde r population than in the SCI/D population. Thus, patien t-specific risk factors and overall treatment needs are different.
The panel determined that additional research is needed in clinical care planning for PU prevention. The majority of at-risk patients, particularly individuals with SCI/D, can ne ver be considered riskfree, although the absolute level of risk for an individual may vary over time. Furthermore, the predominant risk factors in the acute-care setting are different from thos e in community-dwelling population or long-term-c are settings. The panel considered that research is needed to determine the need for different clinical care planning to address the different effects of episodically varying risk factors such as infection and chronic risk factors such as muscle atrophy.
The panel discussed clin ical-care planning for continuous PU prevention and unanimously agreed that all PUs may not be preventable. A 1-day consensus panel on this issue wa s hosted by the NPUAP in February 2010 [65] . Given that the strongest predictor of PU development is having had a previous ulcer, anyone with a previ ous PU has to be considered at high ris k for recurrence [66] . At present, the long-term follow-up of i ndividuals whose PUs are healed varies. No evidence is available to guide clinical practice on what types of follow-up interventions these high-risk individuals should receive once their ulcer is healed. In many case s, clinical staff is s o busy treating PUs that pr evention may not receive attention or resources adequate to address the magnitude of the problem. It may be more effective to manage individuals with SCI/D and a history of PUs as if they have a chron ic systemic disease, similar to diabetes or COPD. For example, to optimize skin health, continuing risk-factor management and patient/caregiver awareness training should be provided to reduce both recurrence and further complic ations. The panel discussed whether a patient-centered or wound-centered approach wo uld be more ef fective for long-term prevention. Pa tient-centered treatment models are relatively novel in PU management, and the panel considered that clinical research studies are needed prior to implementation.
Acute Care and Bed Rest
The SCICPG recommen d universal precautions for PU prevention, including turning every 2 hours while in bed for at-risk i ndividuals. While this is a standard practice in the Un ited States, the clinical practice in Europe (guided by the European Pressure Ulcer Advisory Panel guidelines) recommends individualized repositioning fr equency based on patient factors and support surface [67] . The research basis for the 2-hour recommendati on is inadequate [68] . Moreover, a recent meta-analysis by Krapfl and Gray found limited evidence that 4-hourly turning, when combined with an appropriate pressure redistribution surface, is equally ef fective as a 2-hourly turning regime [69] . The panel agreed with the SCICPG authors in recommending that further research is needed to determine optimal turning intervals.
The SCICPG recommend implementing PU prevention strategies during acute SCI to avoid prolonged immobilization. Unfortunately, implementation can be difficult during the acute postinjury period in the presence of bulky but medically necessary devices such as ventilators and external fixation devices. Optimally identifying at-risk individuals and early tissue damage and implementing preventive measures require an interdisciplinary team that brings together many different clinical skills. The implementation of interdisciplinary wound teams and specialized "turn teams" has been correlated with reduce d incidence of PUs at a ll levels of patient care [70] [71] [72] [73] . However , these teams were frequently implemented at the same time as other interventions. Therefore, the specific ef fect of the wound teams is dif ficult to ascertain without further research.
Determination of best practices for team composition and interaction is likely to be critically important [74] . It is rec ognized that not all disciplines will have the sa me professional education background or educational approach to PU management.
Skin Assessment
Best practices for conducting skin inspections and wound-care rounds in hospitals have not been established. Likewise, the frequency and techniques for skin inspection in either the home or long-termcare setting are ill-defi ned. Despite the SCICPG recommendation for daily vi sual and tactile skin inspections, the expert panel agreed that visual skin assessment (VSA) remains an inadequate method for accurate prediction of PU development. There is evidence that VSA is difficult to carry out routinely for patients and provide rs. Although several risk assessment tools are currently in use, most of these tools demonstrate inappropriate sensitivity and specificity when applied to individuals with SCI/D. In addition, there appears to be some disagreement on the clinical ef fect of implementing routine risk assessment [75] [76] [77] . The expert panel considered that further research on how to provide timely and accurate feedback about risk factors to individuals with SCI/D and their caregivers is sorely needed.
Tissue Health Assessment
Although the assessment of PU risk is the goal of the SCICPG , several known risk factors currently cannot be assessed practically. For example, both normal and shear for ces are known to be significant risk factors. Clin ical pilot studies have shown a strong associati on with duration of loading, particularly acutely following traumatic SCI [78] [79] [80] . Assessing shear di rectly would aid risk assessment. While theoretica l models of the ef fect of shear stresses have been developed [81] [82] [83] , appropriate sensors are at an early stage of development for clinical use [84] . The panel considered that research is needed to validate mathematical models incorporating the ef fects of shear stresses and to develop shear measurement devices. This preclinical research is needed prior to implementation as a component of clinical management.
Support Surface Technology
Although the SCICPG r ecommends many support surface and positioning methods for preventing and treating PUs, no uniform method or schedule for conducting a seating/support surface evaluation i s available. Variability in data collection, interpretation, and use of quantitative measures is a barrier to the development of eviden ce-based guidelines for seating prescriptions [85] [86] . For example, the best way to use the informati on obtained through interface pressure mapping is unknown [87] . The panel considered that further research is needed on support surface technologies and their implementation.
The standard of care fo r PU healing remains prolonged bed rest. In individua ls with SCI/D, this is associated with other comorbidities, loss of function, and social isolation. Although prone carts are routinely used in the rehabilitation ho spital setting, they remain impractical for use in most community settings. Current research into altern ating-pressure support-surface technologies may redirect the PU prevention and treatment approach to pressure relief [88] . Ultimately, however, despite all impr ovements in support surface technology a universal optimal therapy is unlikely . Research-based principles that would allow individualized treatments based on each person's array of risk factors and environment have yet to be developed.
Pressure Ulcer Treatments
PU management can be classified broadly as either conservative or surgical. Conservative management can include both systemic (e.g., nutritional) and topical interventions (e.g., dressing change).
Treatments for PUs vary wi dely based on the stage and characteristics of the wound, e.g., amount of drainage, bacterial load, and presence of slough or eschar. The multiplicity of factors makes determining the standard treatment protocol for PUs difficult. Good data on which patients would benefit from conservative as opposed to surgical treatment are lacking. It may be beneficial to develop an algorithm or decision tree for PU treatment. Further research is needed to determine w hich treatments best promote complete healing under wh at circumstances. Ultimately, the development of evidence-based g uidelines for the personalization of PU care would be beneficial.
Even when certain PU principles are commonly accepted, further research is required to determine best practices. For exampl e, provision of a moist healing environment is known to promote ulcer healing [89] [90] [91] , but optimal conservative methods for controlling moisture in the wound require further research. Controlled cl inical studies of topical agents in PU manageme nt, a commonly accepted practice, have tended to use pre-post test study designs, focusing on interventions involving a single product [92] [93] . A comp arative effectiveness trial would be lar ge and likely to become rapidly obsolete since new agents and dressings are continuously being released. A st andardized assessment methodology based on quantitative benchmarks for wound healing would facilit ate direct comparison of different types of intervention.
Another commonly accepted principle for wound healing is debridement. De bridement is a technique employed to remove necrotic materials from the PU and to promote healing. It can be divided into three major categories: enzymatic, mechanical, an d sharp debridement. There are currently n o standardized guidelines for best clinical practices in debridement to facilitate PU healing. The panel considered that clinical research is needed to determine both selection of technique and timing of debridement.
The surgical management of PUs remains controversial because of the high rate of recurrence after flap closure [16, [94] [95] [96] . Further research is needed to clarify the role for sur gery in PU treatment, because many questions remain. For example, it is unknown whether surgical intervention decreases recurrence of PUs compared with more conservative treatments or whether it may increase in cidence of PUs in other locations during the recovery process. There are other important postoperative practices for individuals with SCI/D for which there is li ttle evidence to guide care, such as length of bed rest and progression of seating trials, which remain largely based on clinician practice and preference rather than empirical evidence. Collaboration between sur geons and re habilitation teams in postoperative care may improve outcomes [97] . Further research is needed to determine the best clinical pathways for sur gical management of PUs. Topics of interest include management of the preand postoperative risk fact ors, identification of the patient and provider factors that are most predictive of surgical success, determination of the intr aoperative precautions that should be taken to prevent additional skin breakdown, and establishment of the best practices for closu re surgeries to improve success rates and decreased recurrence. Additionally , the panel is still concerned regarding how to sustain adequate surgical support to perform these challenging surgeries in the future.
Home Management
PU prevention and treatment for the person with SCI/D living at home vary widely depending on a number of factors, includi ng the individual's level of injury and functional abil ity; availability of support services such as home nursing and health aides; and caregiver availability, clinical skills, and physical abilities. Demands on patients and caregivers dealing with a PU at hom e can be overwhelming, especially when external resources are limited. The panel recommended furthe r research on best practices for helping caregivers manage at home.
The panel discussed the role that communications or distance technology could play in improving patient home care by co ntinuing patient education and interactions with clin icians. Patient-specific information on PU risk factors could be made available to individuals, either on demand or regularly. In turn, the individual with SCI/D could have improved remote access to relevant information and expert clinical advice. The enhancement of patient/clinician interactions, with person alized near-real-time feedback, could facilitate secondary prevention of PUs. Research is needed to evaluate whether technologies such as home telehealth, social messaging platforms, text messages, or "blogs " would pr omote adoption of protective behaviors and/ or early notification of tissue damage, i.e., stage I PUs [98] [99] when potentially, clinicians have an opportunity to make a difference in the course of the ulcer.
Recurrent Pressure Ulcers
The NPUAP staging model states that once a PU develops, it is always de scribed as at the maximum stage [100]. For example, if an individual has a grade IV right ischial PU during acute rehabilitation, any further right ischial breakdown should always be classified as grade IV. The current NPUAP terminology implies that this grading system should be applied even if the second event is 20 years later and only involves superficial breakdown. However, the panel deemed that the lack of a reliable and valid classification system for staging recurrent PUs is problematic. Should a wound returning a month later in a person with a healed PU be considered new or old? If a wound develops elsewhere but tunnels to a previous PU site, is this classified as the same ulcer? These issues should be systematically addressed to determine the true prevalence and incidence of recurrent PUs.
Characterization of Wound Healing and Chronic Wounds
The current staging model also lacks clarification of the various physiological phases of wound healing. It is important to clea rly develop a standardized definition of healing and a reliable way to determine if a wound is fully healed. The relationships between the clinical appearance of a healing wound, the physiological properties of the wound, and clinical outcomes are not well understood. Current definitions of wound healing include epith elialization or covering over of the wound ar ea and require a temporal component to be clinically re levant. It would be beneficial to determine whether biomechanical information, similar to studies of tensile skin strength following surgical incisions, may be applied to healing u lcers to help quantificatify h ealing. This would r equire development of both a precis e clinical definition of wound closure, e.g., wound epithelialization, and a physiological definition based on the tensile strength of wound tissue and collagen organization. At this time, we lack cost-ef fective and noninvasive techniques that can be applied clinically to determine whether a wound is fully he aled. Research in these areas would help determ ine which tr eatments promote complete healing.
Complicating the staging of PUs in individuals with SCI/D are those patie nts who develop chronic nonhealing ulcers. Further study is needed to determine at what point a woun d should be categorized as nonhealing. It is unclear whether patients can live safely with prolonged op en wounds because of a lack of longitudinal studie s of nonhealing PUs. W e need a more rigorous clinical definition of recurrence in nonhealing wounds. Clinical approaches to managing patients with chronically nonhealing wounds remain ill-defined and should be further investigated.
Tertiary Prevention of Complications
Conventionally, long-term bed rest has been an important component of conservative management for PU healing. In individuals with SCI/D, bed rest is associated with loss of function and other comorbidities such as deconditioni ng, respiratory compromise, and social isolation [101] . Deconditioning, in turn, increases the ris k of furt her complications such as pneumonia, with a highly deleterious effect on patient recovery. It may therefore be beneficial to allow patients to mobilize before a PU is fully healed. Questions remain regarding the appropriate therapy regimen to prevent complicati ons of immobility . For example, should bedside ca rdiovascular exercise be used routinely to prevent deconditioning? If so, how should it be implemented su ch that worsening of the pressure ulceration is prevented? There is no evidence to guide clinical practice in determining activity levels to protect respiratory and functional health during conservative PU management. The panel considered that clinical s tudies are needed to evaluate wheth er PUs can heal ef fectively without complete bed rest. As a corollary to this approach, development of evidence-based activity crite ria would be inv aluable for safely increasing sitting time and patient discharge to the community prior to healing.
Comprehensive assessment of the patient is important, as emphasized in the SCICPG , because PU development is considered a serious complication of SCI/D, which is associ ated with additional lifethreatening complications. The most frequent cause of death among veterans with SCI/D was sepsis associated with genitourinar y and PU sequelae [102] . However, the current mortality rate for PU-related complications in the population with SCI/D is not well characterized.
Multiple morbidities are associated with presence of PUs, such as osteomyelitis, bacteremia, and sepsis [103] [104] . PU sur geries have been associated with wound dehiscence, postoperative hematoma/seroma, necrotizing fasciitis [105] , and development of new intraoperative PUs. The incidence and prevalence of these complications are va riably defined. The best means for tertiary prevention of such complications also remain unclear . Once complications develop, treatments remain largely provider-dependent rather than being primarily evidence-based. Additional research is recommended in these areas.
As previously stated, i ndividuals with SCI/D are always at some level of risk for developing PU and subsequent infection. There is particular concern for patients with chronic nonhealing wounds, who typically have polymicrobial wound colonization associated with slowing of the wound healing process [106] . Colonization may eventually lead to local osteomyelitis or systemic infections. Though not the current practice, long-term prophylactic antibiotics have been used in the prevention of urinary tract infections and other complications of SCI/D [107] . Some clinicians believe these antibiotics may b e useful for treating chronic osteomyelitis. However, it is unclear whether longterm prophylactic antibiotics ar e beneficial in tertiary prevention of morbidity and mortality due to SCI/Drelated wound infection. Unfo rtunately, this strategy may also lead to the evolu tion of antibiotic-resistant bacteria and cause dif ficulty in identifying ef fective therapy [108] [109] . The panel considered that additional research is needed to evaluate the relative benefits of long-term antibiotic s with res pect to tertiary prevention of PU complications in SCI.
Environment of Care
The provision of care for preventing and treating PU in persons with SCI/D occurs in a variety of settings, from the acute to chronic, from inpatient to the community. Patient needs and the reso urces available for care vary based on level of injury and socioeconomic factors: level of education, insurance availability, and family s upport structure, to name a few. Consequently, there are significant challenges to care planning in this population, such as how to optimize provider team awareness, personnel/caregiver planning and stability, and administrative support of care systems in the population with SCI/D.
The SCICPG support tailoring PU prevention programs to specific patient populations. Facilities need to determine the best way to implement and maintain the SCICPG . However, all recommendations are given equal weight of importance, which is impractical for clinical implementation and may impair the capability of healthcare systems to prioritiz e how limited resources are allocated. As mentioned, the ef fect of adhering to CPG-recomme nded behaviors can be studied from several perspectives, which may include outcomes such as cost-benefit analysis, quality improvement, risk management, and patient satisfaction. Research is needed to develop appropriate and weighted guidelines that would optimize allocation of resources for all levels of prevention. It is believed that curr ent distribution of healthcare resources focuses more on treatment of PUs and their morbidities than on primary prevention. Unfortunately, the complete true costs of PU prevention and care-ranging from direct clinical expenses such as treatments and dur able medical equipment to indirect costs such as loss of income, mobility , and independence-remain unknown. From the system standpoint, desire for lower costs and decreased liability may drive calls for the derivation of evidence-based-care algorithms from weighted CPGs, e.g., implementation of multidisciplinary wound teams in the acute and long -term acute care facility. It is important, therefore, to determine the cos teffectiveness of specific treatments and prevention activities [110] [111] . Further research is needed in this area. The exact circumstances under which veterans with SCI/D continue to receive care for skin breakdown at VA spoke sites vers us being transferred to the hub site for PU care are not well understood. If PU care was more formally comanaged between the hub and spokes, real-tim e information on the number of stage II or grea ter ulcers and available resources to man age them could be shared. There would be better information about the magnitude of the problem within the system of care and there could be more centralized discussion about how best to deploy resources under this scenario. Technology, including video conf erencing or other telehealth applications, may f acilitate such clinical collaboration on care for patients at remote sites. Recent External Peer Review Program data * suggest that in the populatio n of veterans with SCI/ D, the majority of P Us are acquired at home. Most prevention strategies address the role tha t institutions play in prevention. However , very few lar ge scale studies address how best to help communitydwelling persons with SCI prevent skin b reakdown. Further implementation research is n eeded in this area. For example, studies focused on the dischar ge planning interface between hospital care and home care would be beneficial. Research is needed on best practices for providing cont inuity of home care to meet the PU prevention and treatment needs of patients with SCI.
RESEARCH PRIORITIZATION SURVEY RESULTS
Panel participation in the survey was 81.8 percent. In the area of risk factor research ( Figure 1) , the panel's highest-priority research topics are advanced imaging for early PU detection (18.5%), biomarkers for PU development (18.5%), deep tissue load and internal-tissue strains (11.1%), nutritional status and management (1 1.1%), and weighted risk factor models (11.1%). For education (Figure 2) , the panel's highest-priority research topics are the development of ef ficacious learning tools for patients (33.3%), development of ef ficacious learning tools for caregivers (22.2%), and promotion of interdisciplinary team knowledge (22.2%). In clinical management (Figure 3) , the highest-priority research topic is the pathway for conservati ve and sur gical management (18.5%), followed by the effect of interdisciplinary wound teams (1 1.1%), standardization of seating/support surface evaluation (11.1%), and telehealth assessment (11.1%). Highest-priority research topics in environment of care ( Figure 4) include the systematic implementation of standardized PU ca re programs (38.9%), methods for effective transition of PU care from the inpatient to home settings (22.2%), and best practices for the management of patients with SCI and PU w ho reside far from an SCI Center (16.7%). The panel hopes that the coordinated development of this prioritized re search agenda will spur future PU research and in crease funding sources to finance such endeavors.
CONCLUSIONS/RECOMMENDATIONS
The consensus of the pane l is that several critical knowledge gaps exist in the PU research base. One of the largest issues is our current inability to predict when an individua l with SCI/D is developing an occult PU. Resear ch on biomarkers of PU formation and healing a nd advanced imaging techniques for early PU detection are very high-priority items. Better understandi ng of nutritional risk factors and therapies, as well as enhanced insight into the relationship between in ternal tissue forces and PU formation, will also aid us in the principal goal of primary prevention.
The panel also opined that we are falling short in our efforts to educate patients, families, and caregivers about optimal PU prev ention and care in community settings. Developing effective learning tools for patient, family, and caregiver education on both prevention and treatment of PUs is a high priority . There also remains room to improve our utilization of interdisciplinary teams for preventing and treating PUs in the inpatient setting. From the clinical manage ment perspective, the panel considered that rese arch to more rigorously define pathways for both conserva tive and sur gical management of PUs is most important, together with the need to stan dardize of evaluation methods for seating and support-surf ace interfaces. The ef fect of interdisciplinary wound teams is also of hi gh interest because they are believed to improve both prevention and healing of PUs in hosp ital settings. Furthermore, improved understanding of the appropriate implementation of telehealth evaluation methods may help prevent and treat PUs in individuals with SCI and PU(s) in the community setting.
Research on the environment of care ranging from inpatient to community settings remains underdeveloped. The panel deemed systematic implementation of standardized PU prevention and care programs the highest priority.
Clearly, many critical multidisciplinary targets remain for PU research, ranging from primary to tertiary prevention, from cellular mechanisms of healing to treatment methodologies. Extensive research is needed in the basic sciences and clinical applications, as well as on the lar ge scale implementation of evidence-based clinical practice. The panel identified several important areas of research within the CPGs. The panel also concluded that certain evidence-based research on SCICPG topics , such as tissue-imaging technology, is nearing read iness for implementation trials.
It is a lso important that research addresses pathways to change in the healthcare system to effectively put new findings into ope ration. Effective change requires a culture of c ontinuous educations and improvement, complimented by a willingness to change when new evidence becomes available. It may be beneficial to model our efforts on VA National Systems Redesign techniques [1 12 ] to expe dite timely adoption of EBP for preventing and treating PUs. Successful advancement of PU prevention across the V A system will decrease treatment costs and improve quality of life for our veterans with SCI/D. It may also serve as a model for care system changes for individuals with SCI/D ac ross the country and throughout the world.
